2025 Introductory Course for Biologics Development and Manufacturing

The 2025 Introductory Course for Biologics Development and Manufacturing aims to provide training on the fundamentals of biologics development and manufacturing under the Global Training Hub for Biomanufacturing (GTH-B), supported by the Ministry of Health and Welfare (MoHW) of the Republic of Korea and WHO. This 2-week introductory training program covers essential topics across various fields related to biologics development and manufacturing. Designed for participants who are from countries officially classified as LMICs on the OECD DAC list and currently involved in the productions of bioproduct, this program offers a great chance to network with 150+ vaccine and biomanufacturing professionals worldwide.

Course Information (In-person training, Republic of Korea) 

• Course Content: Basic knowledge of pre-clinical & clinical trials, biologics manufacturing process, quality control, quality assessment, and regulatory affairs for the development and manufacturing of vaccines and biologics
• Course Duration: 10 working days (2 calendar weeks)
• Faculty: Area-specific experts
• Hours of Training: 80 hours including a mini convention, interactive sessions, and excursions
• Excursion Sites: Hospital clinical centers, biomedical product development and research sites, manufacturing sites
• Target Trainees: 120 trainees from LMICs and Republic of Korea
• Certificate of completion:  Participants who complete 100% of the pre-online sessions and at least 90% of all required quizzes during the in-person course will receive a certificate of completion.